NCT04374656View on ClinicalTrials.gov

Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

May 29, 2024

Study Completion Date

May 29, 2024

Conditions
ConjunctivitisSARS-CoV-2COVID-19Ocular Infection, ViralOcular Inflammation
Trial Locations (1)

21287

Wilmer Eye Institute, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04374656 - Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic | Biotech Hunter | Biotech Hunter